Investment in Associates (Details) - USD ($) $ in Thousands |
12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mar. 25, 2025 |
Feb. 25, 2025 |
Mar. 11, 2024 |
Nov. 25, 2023 |
Feb. 17, 2023 |
Mar. 10, 2022 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Investment in Associates [Line Items] | ||||||||||
| Initial Investment | $ 700 | |||||||||
| Additional investment | $ 400 | |||||||||
| Number of shares (in Shares) | 365,444 | 57,293 | 3,739 | |||||||
| Total outstanding percentage | 17.70% | |||||||||
| Capital gain | $ 2,231 | |||||||||
| Equity losses from the investment | (500) | (429) | (210) | |||||||
| MitoCareX [Member] | ||||||||||
| Investment in Associates [Line Items] | ||||||||||
| Outstanding shares | 31.48% | |||||||||
| Additional investment | $ 600 | |||||||||
| Additional investment | $ 600 | |||||||||
| Installment paid | $ 600 | |||||||||
| Proceeds from issuance of shares | $ 700 | |||||||||
| Number of shares (in Shares) | 490,751 | |||||||||
| Equity losses from the investment | $ 500 | $ 429 | $ 210 | |||||||
| MitoCareX [Member] | Bottom of range [Member] | ||||||||||
| Investment in Associates [Line Items] | ||||||||||
| Ownership percentage | 41.92% | 31.48% | ||||||||
| MitoCareX [Member] | Top of range [Member] | ||||||||||
| Investment in Associates [Line Items] | ||||||||||
| Ownership percentage | 52.73% | 41.92% | ||||||||